# OnCo record carotuximab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/carotuximab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "carotuximab" ;
  schema:name "Carotuximab"@en ;
  schema:alternateName "TRC105"@en ;
  schema:description "Carotuximab was an antibody against endoglin, a protein on growing blood vessels and on angiosarcoma cells. Added to pazopanib in the phase 3 TAPPAS trial it did not help, and the trial was stopped in 2019."@en ;
  schema:url <https://onco.cc/drugs/carotuximab/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:status "negative" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Chimeric anti-endoglin (CD105) monoclonal antibody" ;
  onco:related <https://onco.cc/drugs/pazopanib/> ;
  onco:cancers <https://onco.cc/cancers/angiosarcoma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:companies <https://onco.cc/companies/tracon/> .